Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study).
Trikha M, Sarkar L, Dhanawat A, Syed N, Gujarathi H, Vora M, Sivakumar Raja AS, Bhargava P, Ramaswamy A, Mandavkar S, Saklani A, Kaushal RK, Bal M, Shetty O, Yadav S, Ostwal V. Trikha M, et al. Among authors: mandavkar s. JCO Glob Oncol. 2024 Aug;10:e2400141. doi: 10.1200/GO.24.00141. JCO Glob Oncol. 2024. PMID: 39159410
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I. Ostwal V, et al. Among authors: mandavkar s. JAMA Netw Open. 2024 Aug 1;7(8):e2426076. doi: 10.1001/jamanetworkopen.2024.26076. JAMA Netw Open. 2024. PMID: 39106066 Free PMC article. Clinical Trial.
Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial.
Ramaswamy A, Bhargava P, Srinivas S, Kapoor A, Mishra BK, Gupta A, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Naughane D, Daddi A, Mer N, Shetty N, Ostwal V. Ramaswamy A, et al. Among authors: mandavkar s. J Clin Oncol. 2024 Sep 20;42(27):3218-3227. doi: 10.1200/JCO.23.02420. Epub 2024 Aug 5. J Clin Oncol. 2024. PMID: 39102628 Clinical Trial.
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers.
Ramaswamy A, Bhargava P, Dubashi B, Gupta A, Kapoor A, Srinivas S, Shetty O, Jadhav P, Desai V, Noronha V, Joshi A, Menon N, Patil VM, Mishra BK, Sansar B, Singh A, Patel S, Singh SN, Dhal I, Vinayak KR, Pal V, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Shah A, Ganesan P, Kayal S, Ananthakrishnan R, Syed N, Samaddar D, Kapu V, Shah A, Kaaviya D, Suganiya R, Srinivasan ND, Prabhash K, Ostwal V. Ramaswamy A, et al. Among authors: mandavkar s. JNCI Cancer Spectr. 2024 Jul 1;8(4):pkae054. doi: 10.1093/jncics/pkae054. JNCI Cancer Spectr. 2024. PMID: 39067037 Free PMC article. Clinical Trial.
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical Trial.
Ostwal V, Patkar S, Engineer R, Parulekar M, Mandavkar S, Bhargava P, Srinivas S, Krishnatry R, Gudi S, Kapoor A, Pandey D, Patel S, Singhal A, Goel A, Dora TK, Chaudhary D, Chaugule D, Naughane D, Daddi A, Patil R, Ankathi SK, Ramaswamy A, Goel M. Ostwal V, et al. Among authors: mandavkar s. JAMA Oncol. 2024 Aug 1;10(8):1116-1120. doi: 10.1001/jamaoncol.2024.1944. JAMA Oncol. 2024. PMID: 38958997 Clinical Trial.
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB).
Ostwal V, Mandavkar S, Bhargava P, Srinivas S, Kapoor A, Shetty O, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Baheti AD, Mehta D, Kaushal RK, Yadav S, Shah A, Patkar S, Goel M, Ramaswamy A. Ostwal V, et al. Among authors: mandavkar s. J Clin Oncol. 2024 Mar 1;42(7):800-807. doi: 10.1200/JCO.23.01193. Epub 2023 Nov 9. J Clin Oncol. 2024. PMID: 37944079 Clinical Trial.
Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers.
Gedela S, Munot P, Vaidyanathan A, Joarder R, Chaugule D, Parulekar M, Nashikkar C, Ghadi A, Vadodaria D, Goel M, Patkar S, Mandavkar S, Ramaswamy A, Bhargava P, Srinivas S, Ostwal V. Gedela S, et al. Among authors: mandavkar s. J Gastrointest Cancer. 2024 Mar;55(1):263-269. doi: 10.1007/s12029-023-00946-z. Epub 2023 Jun 27. J Gastrointest Cancer. 2024. PMID: 37368175
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).
Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav VK, Shinde S, Jadhav S, Gota V, Mittra I. Ostwal V, et al. Among authors: mandavkar s. Med Oncol. 2022 Nov 13;40(1):17. doi: 10.1007/s12032-022-01862-1. Med Oncol. 2022. PMID: 36372825 Clinical Trial.
Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).
Ostwal V, Ramaswamy A, Gota V, Bhargava PG, Srinivas S, Shriyan B, Jadhav S, Goel M, Patkar S, Mandavkar S, Naughane D, Daddi A, Nashikkar C, Shetty N, Ankathi SK, Banavali SD. Ostwal V, et al. Among authors: mandavkar s. Oncologist. 2022 Mar 11;27(3):165-e222. doi: 10.1093/oncolo/oyab008. Oncologist. 2022. PMID: 35274724 Free PMC article. Clinical Trial.
21 results